197 related articles for article (PubMed ID: 35637862)
1. Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study.
Tanaka J; Kurisu A; Ohara M; Ouoba S; Ohisa M; Sugiyama A; Wang ML; Hiebert L; Kanto T; Akita T
Lancet Reg Health West Pac; 2022 May; 22():100428. PubMed ID: 35637862
[TBL] [Abstract][Full Text] [Related]
2. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.
Chen LP; Zhao J; Du Y; Han YF; Su T; Zhang HW; Cao GW
World J Virol; 2012 Dec; 1(6):174-83. PubMed ID: 24175223
[TBL] [Abstract][Full Text] [Related]
3. Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis.
Tmu N; Kumar A; Sharma P; Singla V; Bansal N; Arora A
J Clin Exp Hepatol; 2019; 9(1):4-12. PubMed ID: 30765933
[TBL] [Abstract][Full Text] [Related]
4. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.
Gupta V; Kumar A; Sharma P; Bansal N; Singla V; Arora A
J Clin Exp Hepatol; 2015 Jun; 5(2):134-41. PubMed ID: 26155041
[TBL] [Abstract][Full Text] [Related]
5. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
6. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
7. The future of liver transplantation for viral hepatitis.
Durand F; Francoz C
Liver Int; 2017 Jan; 37 Suppl 1():130-135. PubMed ID: 28052618
[TBL] [Abstract][Full Text] [Related]
8. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
9. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
[TBL] [Abstract][Full Text] [Related]
10. Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia.
Premkumar M; Chawla YK
J Clin Exp Hepatol; 2022; 12(1):144-154. PubMed ID: 35068795
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan.
Younossi ZM; Tanaka A; Eguchi Y; Henry L; Beckerman R; Mizokami M
J Viral Hepat; 2018 Aug; 25(8):945-951. PubMed ID: 29478258
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Yeh ML; Hung CH; Tseng KC; Lai HC; Chen CY; Kuo HT; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Huang CF; Huang JF; Dai CY; Chuang WL; Tsai PC; Peng CY; Liu CJ; Yu ML
Hepatol Int; 2021 Oct; 15(5):1109-1121. PubMed ID: 34365587
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring patients with chronic hepatitis during and after therapy].
Colić-Cvrlje V; Mise S
Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
[TBL] [Abstract][Full Text] [Related]
14. [The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection].
Garbuzenko DV
Vopr Virusol; 2021 Nov; 66(5):331-339. PubMed ID: 34738448
[TBL] [Abstract][Full Text] [Related]
15. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
Chu CJ; Lee SD
J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
[TBL] [Abstract][Full Text] [Related]
17. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
Perz JF; Armstrong GL; Farrington LA; Hutin YJ; Bell BP
J Hepatol; 2006 Oct; 45(4):529-38. PubMed ID: 16879891
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
19. Relation of Reduction of Antibodies against Hepatitis B Virus to Hepatocellular Carcinoma Recurrence in the Patients with Resolved Hepatitis B Virus Infection Following Direct-acting Antiviral Therapy for Hepatitis C Virus Infection.
Joko K; Mashiba T; Ochi H; Yano R; Sato K; Okujima Y; Aono M; Azemoto N; Takechi S; Yokota T; Jinoka R; Moriyama Y; Nishiyama M
Euroasian J Hepatogastroenterol; 2019; 9(2):78-83. PubMed ID: 32117695
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.
Butt AA; Yan P; Aslam S; Sherman KE; Siraj D; Safdar N; Hameed B
Int J Infect Dis; 2020 Mar; 92():184-188. PubMed ID: 31978574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
